PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24831826-4	2014	Excitingly, a selective AP-1 inhibitor T-5224 (51) has been investigated in phase II human clinical trials.	3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid	39-45	JunB proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	24-28